Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02BOG
|
||||
Former ID |
DNC014236
|
||||
Drug Name |
H-Tyr(OMe)-Phe(2-Me)-NH2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H25N3O3
|
||||
Canonical SMILES |
CC1=CC=CC=C1CC(C(=O)N)NC(=O)C(CC2=CC=C(C=C2)OC)N
|
||||
InChI |
1S/C20H25N3O3/c1-13-5-3-4-6-15(13)12-18(19(22)24)23-20(25)17(21)11-14-7-9-16(26-2)10-8-14/h3-10,17-18H,11-12,21H2,1-2H3,(H2,22,24)(H,23,25)/t17-,18-/m0/s1
|
||||
InChIKey |
DZDNCKHJPMLWQZ-ROUUACIJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Substance-P receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Measles | |||||
PANTHER Pathway | CCKR signaling map ST | ||||
Reactome | G alpha (q) signalling events | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Spinal Cord Injury | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | J Med Chem. 2010 Mar 25;53(6):2383-9.Discovery of dipeptides with high affinity to the specific binding site for substance P1-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.